Podcast: Implementing a Low Dose Mammography Solution
Raymond Tu, MD, discusses the considerations for implementing a new lower dose mammography system, including patient safety, market share, and cost.
[[{"type":"media","view_mode":"media_crop","fid":"11562","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_9305716539806","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"205","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]When United Medical Center in Washington, D.C., upgraded their film-screen mammography system, they had several factors to consider, including how to best meet the needs of their underserved patient population while keeping costs in mind.
The push to lower radiation dose was also a major factor, said Raymond Tu, chairman of the Radiology Department at UMC and president of the American College of Radiology's Washington, D.C., chapter. In this podcast, Tu discusses why UMC opted for Philips’ MicroDose Mammography system, which the company launched in North America last fall.
Here, Tu details:
• The unique needs of his patient population, and how that factored into the selection of a new technology,
• The desire to select a solution that would help the group’s market share in the area, and
• The constraining factors keeping the industry from doing more to implement lower dose technologies.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
